|
Our keynote speakers
John Mathias
Head of HTS CoE
Pfizer
George Keseru
Head of Discovery Chemistry
Gedeon Richter
Ulrich Hassiepen
Research Investigator II
Novartis
Peter Greasley
Lead Generation Science & Strategy Manager
AstraZeneca
Murray Brown
Manager, Data Interpretation and Business Process, Screening and Compound Profiling
GlaxoSmithKline
|
Our expert speakers
Francois Bertelli, Senior Principal Scientist, Pfizer
Willem Nissink, Research Scientist & Computational Chemist, AstraZeneca
Ann Wheeler, Advanced Imaging Facility Manager, Queen Mary, University of London
Niklas Blomberg, Associate Director, Computational Chemistry, AstraZeneca
Nicola Richmond, Investigator, GlaxoSmithKline
Michel Detheux, Director, Euroscreen FAST Business Unit, Euroscreen
Stefan Schmitt, Team Leader, Computational Chemistry, AstraZeneca
Alessandro Esposito, Senior Investigator Scientist, MRC Cancer Cell Unit, University of Cambridge
James Campell, Director, Lead Generation, AstraZeneca
Peter O'Brien, Veterinary Clinical Pathologist, University College Dublin
Katya Tsaioun, President, Apredica
Peter Ghazal, Head of Division of Pathway Medicine, University of Edinburgh
Wolfgang Wenzel, Scientist, Institute for Nanotechnology, Karlsruher Institute of Technology
|